$220.22
1.08%
NYSE, Sep 25, 04:00 pm EDT. Closed.
ISIN
US14149Y1082
Symbol
CAH

Cardinal Health Target price 2026 - Analyst rating & recommendation

Cardinal Health Classifications & Recommendation

Buy
88%
Hold
13%

Cardinal Health Price Target

Target Price $281.01
Price $220.22
Potential
Number of Estimates 19
19 Analysts have issued a price target Cardinal Health 2027 . The average Cardinal Health target price is $281.01. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 24 analysts: 21 Analysts recommend Cardinal Health to buy, 3 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Cardinal Health stock has an average upside potential 2027 of . Most analysts recommend the Cardinal Health stock at Purchase.

Sales and Margin forecast 2027, 2028 to 2030

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Jun '26 2027
Estimates
Revenue Billion $ 254.25 268.36
14.23% 5.55%
EBITDA Margin 1.43% 1.71%
14.44% 19.38%
Net Margin 0.67% 1.10%
3.88% 63.17%

20 Analysts have issued a sales forecast Cardinal Health 2027 . The average Cardinal Health sales estimate is

$268b
unlock
. This is
5.55% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$282b 10.82%
unlock
, the lowest is
$258b 1.58%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2026 $254b 14.23%
2027
$268b 5.55%
unlock
2028
$286b 6.75%
unlock
2029
$303b 5.86%
unlock
2030
$341b 12.51%
unlock

18 Analysts have issued an Cardinal Health EBITDA forecast 2027. The average Cardinal Health EBITDA estimate is

$4.6b
unlock
. This is
26.06% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$5.2b 43.63%
unlock
, the lowest is
$4.1b 11.97%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2026 $3.6b 30.73%
2027
$4.6b 26.06%
unlock
2028
$5.0b 9.21%
unlock
2029
$5.4b 7.24%
unlock

EBITDA Margin

2026 1.43% 14.44%
2027
1.71% 19.38%
unlock
2028
1.75% 2.34%
unlock
2029
1.77% 1.14%
unlock

21 Cardinal Health Analysts have issued a net profit forecast 2027. The average Cardinal Health net profit estimate is

$3.0b
unlock
. This is
72.37% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$3.1b 79.85%
unlock
, the lowest is
$2.9b 66.66%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2026 $1.7b 9.80%
2027
$3.0b 72.37%
unlock
2028
$3.3b 11.83%
unlock
2029
$3.7b 10.54%
unlock
2030
$4.0b 10.86%
unlock

Net Margin

2026 0.67% 3.88%
2027
1.10% 63.17%
unlock
2028
1.15% 4.55%
unlock
2029
1.20% 4.35%
unlock
2030
1.19% 0.83%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2027, 2028 to 2030

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Jun '26 2027
Estimates
Earnings Per Share $ 7.23 12.68
12.09% 75.38%
P/E 17.37
EV/Sales 0.21

21 Analysts have issued a Cardinal Health forecast for earnings per share. The average Cardinal Health EPS is

$12.68
unlock
. This is
73.22% higher
unlock
than earnings per share in the financial year 2026. The highest EPS forecast is
$13.23 80.74%
unlock
, the lowest is
$12.26 67.49%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2026 $7.23 12.09%
2027
$12.68 75.38%
unlock
2028
$14.18 11.83%
unlock
2029
$15.67 10.51%
unlock
2030
$17.38 10.91%
unlock

P/E ratio

Current 30.08 31.32%
2027
17.37 42.26%
unlock
2028
15.53 10.59%
unlock
2029
14.05 9.53%
unlock
2030
12.67 9.82%
unlock

Based on analysts' sales estimates for 2027, the Cardinal Health stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.22 22.22%
2027
0.21 6.82%
unlock
2028
0.19 6.29%
unlock
2029
0.18 5.57%
unlock
2030
0.16 11.08%
unlock

P/S ratio

Current 0.20 24.98%
2027
0.19 5.28%
unlock
2028
0.18 6.32%
unlock
2029
0.17 5.56%
unlock
2030
0.15 11.06%
unlock

Current Cardinal Health Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
RBC Capital
Locked
➜
Locked
Locked Aug 19 2026
Barclays
Locked
➜
Locked
Locked Aug 13 2026
TD Cowen
Locked
➜
Locked
Locked Aug 13 2026
JP Morgan
Locked
➜
Locked
Locked Aug 13 2026
Citigroup
Locked
➜
Locked
Locked Aug 12 2026
Evercore ISI Group
Locked
➜
Locked
Locked Aug 12 2026
Baird
Locked
➜
Locked
Locked Aug 12 2026
Analyst Rating Date
Locked
RBC Capital:
Locked
➜
Locked
Aug 19 2026
Locked
Barclays:
Locked
➜
Locked
Aug 13 2026
Locked
TD Cowen:
Locked
➜
Locked
Aug 13 2026
Locked
JP Morgan:
Locked
➜
Locked
Aug 13 2026
Locked
Citigroup:
Locked
➜
Locked
Aug 12 2026
Locked
Evercore ISI Group:
Locked
➜
Locked
Aug 12 2026
Locked
Baird:
Locked
➜
Locked
Aug 12 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today